Alzheimer's disease meets the ubiquitin–proteasome system

Mudher, 2002, Alzheimers disease – do tauists and baptists finally shake hands?, Trends Neurosci., 25, 22, 10.1016/S0166-2236(00)02031-2 Morishima-Kawashima, 2002, Alzheimer's disease: β-amyloid protein and tau, J. Neurosci. Res., 70, 392, 10.1002/jnr.10355 Dewachter, 2002, Secretases as targets for the treatment of Alzheimer's disease: the prospects, Lancet Neurol., 1, 409, 10.1016/S1474-4422(02)00188-6 Citron, 2004, β-secretase inhibition for the treatment of Alzheimer's disease – promise and challenge, Trends Pharmacol. Sci., 25, 92, 10.1016/j.tips.2003.12.004 Small, 2001, Alzheimer's disease and Aβ toxicity: from top to bottom, Nat. Rev. Neurosci., 2, 595, 10.1038/35086072 Poirier, 2003, Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease, Trends Mol. Med., 9, 94, 10.1016/S1471-4914(03)00007-8 Perry, 1987, Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains, Proc. Natl. Acad. Sci. U. S. A., 84, 3033, 10.1073/pnas.84.9.3033 Ciechanover, 2003, The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg, Neuron, 40, 427, 10.1016/S0896-6273(03)00606-8 Berke, 2003, Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration, Curr. Opin. Genet. Dev., 13, 253, 10.1016/S0959-437X(03)00053-4 Kopito, 2000, Aggresomes and Russell bodies. Symptoms of cellular indigestion?, EMBO, 3, 225, 10.1093/embo-reports/kvd052 Gregori, 1995, Amyloid β-protein inhibits ubiquitin-dependent protein degradation in vitro, J. Biol. Chem., 270, 19702, 10.1074/jbc.270.34.19702 Song, 2003, Essential role of E2–25K/Hip-2 in mediating amyloid-β neurotoxicity, Mol. Cell, 12, 553, 10.1016/j.molcel.2003.08.005 Imai, 2002, CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity, Mol. Cell, 10, 55, 10.1016/S1097-2765(02)00583-X Maraganore, 2004, UCHL1 is a Parkinson's disease susceptibility gene, Ann. Neurol., 55, 512, 10.1002/ana.20017 Wojcik, 2004, Ubiquitin–proteasome system and proteasome inhibition: new strategies in stroke therapy, Stroke, 35, 1506, 10.1161/01.STR.0000126891.93919.4e Keller, 2000, Impaired proteasome function in Alzheimer's disease, J. Neurochem., 75, 436, 10.1046/j.1471-4159.2000.0750436.x Lopez Salon, 2000, Defective ubiquitination of cerebral proteins in Alzheimer's disease, J. Neurosci. Res., 62, 302, 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L Keck, 2003, Proteasome inhibition by paired helical filament–tau in brains of patients with Alzheimer's disease, J. Neurochem., 85, 115, 10.1046/j.1471-4159.2003.01642.x van Leeuwen, 1998, Frameshift mutants of β amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients, Science, 279, 242, 10.1126/science.279.5348.242 Lindsten, 2002, Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation, J. Cell Biol., 157, 417, 10.1083/jcb.200111034 De Vrij, 2001, Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death, FASEB J., 15, 2680, 10.1096/fj.01-0438com Lam, 2000, Inhibition of the ubiquitin–proteasome system in Alzheimer's disease, Proc. Natl. Acad. Sci. U. S. A., 97, 9902, 10.1073/pnas.170173897 Hope, 2003, Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression, J. Neurochem., 86, 394, 10.1046/j.1471-4159.2003.01844.x Fischer, 2003, Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain, FASEB J., 17, 2014, 10.1096/fj.03-0205com Taylor, 2002, Toxic proteins in neurodegenerative disease, Science, 296, 1991, 10.1126/science.1067122 Fraser, 1998, Presenilin 1 is actively degraded by the 26S proteasome, Neurobiol. Aging, 19, S19, 10.1016/S0197-4580(98)00029-3 da Costa, 1999, C-terminal maturation fragments of presenilin 1 and 2 control secretion of APP α and Aβ by human cells and are degraded by proteasome, Mol. Med., 5, 160, 10.1007/BF03402059 Chen, 2002, A novel mechanism for the regulation of amyloid precursor protein metabolism, J. Cell Biol., 158, 79, 10.1083/jcb.200110151 Jin, 2000, The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome, J. Biol. Chem., 275, 38699, 10.1074/jbc.M005543200 Nunan, 2003, Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease β-amyloid protein precursor: effect of C-terminal truncation on production of β-amyloid protein, J. Neurosci. Res., 74, 378, 10.1002/jnr.10646 Bennett, 1999, Degradation of α-synuclein by proteasome, J. Biol. Chem., 274, 33855, 10.1074/jbc.274.48.33855 Tanaka, 2001, Inducible expression of mutant α-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis, Hum. Mol. Genet., 10, 919, 10.1093/hmg/10.9.919 Bence, 2001, Impairment of the ubiquitin–proteasome system by protein aggregation, Science, 292, 1552, 10.1126/science.292.5521.1552 Zhou, 2003, Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity, J. Cell Biol., 163, 109, 10.1083/jcb.200306038 Khoshnan, 2002, Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity, Proc. Natl. Acad. Sci. U. S. A., 99, 1002, 10.1073/pnas.022631799 McNaught, 2002, Proteasome inhibition causes nigral degeneration with inclusion bodies in rats, Neuroreport, 13, 1437, 10.1097/00001756-200208070-00018 Zhang, 2004, Regulation of apoptosis proteins in cancer cells by ubiquitin, Oncogene, 23, 2009, 10.1038/sj.onc.1207373 Qiu, 2000, Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons, J. Neurosci., 20, 259, 10.1523/JNEUROSCI.20-01-00259.2000 Tanaka, 2004, Aggresomes formed by α-synuclein and synphilin-1 are cytoprotective, J. Biol. Chem., 279, 4625, 10.1074/jbc.M310994200 Goldberg, 2003, Protein degradation and protection against misfolded or damaged proteins, Nature, 426, 895, 10.1038/nature02263 Shringarpure, 2002, Protein turnover by the proteasome in aging and disease, Free Radic. Biol. Med., 32, 1084, 10.1016/S0891-5849(02)00824-9 Nishitoh, 2002, ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats, Genes Dev., 16, 1345, 10.1101/gad.992302 Nakagawa, 2000, Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β, Nature, 403, 98, 10.1038/47513 Guo, 1998, Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease, Nat. Med., 4, 957, 10.1038/nm0898-957 Takashima, 1993, Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity, Proc. Natl. Acad. Sci. U. S. A., 90, 7789, 10.1073/pnas.90.16.7789 Jo, 2001, Pro-apoptotic function of Calsenilin/DREAM/KChIP3, FASEB J., 15, 589, 10.1096/fj.00-0541fje Haldeman, 1997, Structure and function of ubiquitin conjugating enzyme E2–25K: the tail is a core-dependent activity element, Biochemistry, 36, 10526, 10.1021/bi970750u Mastrandrea, 1998, Core domain mutation (S86Y) selectively inactivates polyubiquitin chain synthesis catalyzed by E2–25K, Biochemistry, 37, 9784, 10.1021/bi9800911 Coux, 1998, Enzymes catalyzing ubiquitination and proteolytic processing of the p105 precursor of nuclear factor kappaB1, J. Biol. Chem., 273, 8820, 10.1074/jbc.273.15.8820 Whitby, 1998, Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes, J. Biol. Chem., 273, 34983, 10.1074/jbc.273.52.34983 De Pril, 2004, Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases, Hum. Mol. Genet., 13, 1803, 10.1093/hmg/ddh188 Dil Kuazi, 2003, NEDD8 protein is involved in ubiquitinated inclusion bodies, J. Pathol., 199, 259, 10.1002/path.1283 Piotrowski, 1997, Inhibition of the 26 S proteasome by polyubiquitin chains synthesized to have defined lengths, J. Biol. Chem., 272, 23712, 10.1074/jbc.272.38.23712